Clinical characteristics of primary AIHA patients
| . | N* . |
|---|---|
| Patients, N | 308 |
| Male/female | 111 (36)/197 (64) |
| Median age at onset, y (range) | 58 (0-95) |
| <18 y | 10 (3) |
| 18-45 y | 73 (24) |
| 45-65 y | 104 (34) |
| >65 y | 121 (39) |
| AIHA serological type** | |
| Warm, DAT positive for IgG | 131 (43) |
| Warm, DAT positive for IgG+C | 52 (17) |
| CAD | 84 (27) |
| Mixed | 24 (8) |
| Atypical | 16 (5) |
| Median follow-up, mo (range) | 33 (6-372) |
| Alive/dead at time of study† | 221 (72)/63 (21) |
| Died of AIHA | 11/63 (17) |
| . | N* . |
|---|---|
| Patients, N | 308 |
| Male/female | 111 (36)/197 (64) |
| Median age at onset, y (range) | 58 (0-95) |
| <18 y | 10 (3) |
| 18-45 y | 73 (24) |
| 45-65 y | 104 (34) |
| >65 y | 121 (39) |
| AIHA serological type** | |
| Warm, DAT positive for IgG | 131 (43) |
| Warm, DAT positive for IgG+C | 52 (17) |
| CAD | 84 (27) |
| Mixed | 24 (8) |
| Atypical | 16 (5) |
| Median follow-up, mo (range) | 33 (6-372) |
| Alive/dead at time of study† | 221 (72)/63 (21) |
| Died of AIHA | 11/63 (17) |